Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.64%
#2 PulseChain PulseChain +59.45%
#3 BOOK OF MEME BOOK OF MEME +34.33%
#4 Merlin's Seal BTC Merlin's Seal BTC +32.88%
#5 Ontology Gas Ontology Gas +28.49%
#6 Unit Pump Unit Pump +24.72%
#7 Pump.fun Pump.fun +24.72%
#8 Nockchain Nockchain +22.61%
#9 Neiro Neiro +21.92%
#10 ConstitutionDAO ConstitutionDAO +20.25%
Coin of the day
Pleasing Gold Pleasing Gold
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Clasificación en acciones #26675
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Precio por acción
$5.54
Última sincronización: 2024-09-18
Capitalización bursátil
$38.76M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Alimera Sciences, Inc. (ALIM)

Categoría

Healthcare
Margen Operativo de Alimera Sciences, Inc. (ALIM)
Margen Operativo al August 2026 TTM: -2.39%
Según los informes financieros más recientes y el precio de las acciones de Alimera Sciences, Inc., el margen operativo actual (TTM) es -2.39%. Al final de 2022, el margen operativo era -21.50%.
Historial de Margen Operativo de Alimera Sciences, Inc. desde 2006 hasta 2026
Margen Operativo al final de cada año
Año Margen Operativo Cambiar
2026 (TTM) -2.39% 0.00%
2023 -2.39% -88.88%
2022 -21.50% 6,223.53%
2021 -0.34% -65.66%
2020 -0.99% -89.88%
2019 -9.78% -52.50%
2018 -20.59% -55.05%
2017 -45.81% -43.52%
2016 -81.11% -53.33%
2015 -173.81% -55.57%
2014 -391.16% -78.72%
2013 -1,837.82% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
Margen Operativo de empresas similares o competidoras
Empresa Margen Operativo Diferencia de Margen Operativo País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00% -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00% -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00% -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00% -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
22.93% -109.59%
IN
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.